These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3327412)

  • 1. Genetically engineered antibody molecules and their application.
    Morrison SL; Wims L; Wallick S; Tan L; Oi VT
    Ann N Y Acad Sci; 1987; 507():187-98. PubMed ID: 3327412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of genetically engineered antibody molecules.
    Morrison SL; Canfield S; Porter S; Tan LK; Tao MH; Wims LA
    Clin Chem; 1988 Sep; 34(9):1668-75. PubMed ID: 3138036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
    Morrison SL; Johnson MJ; Herzenberg LA; Oi VT
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6851-5. PubMed ID: 6436822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and properties of chimeric antibody molecules.
    Shin SU; Morrison SL
    Methods Enzymol; 1989; 178():459-76. PubMed ID: 2513467
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel strategy for producing chimeric bispecific antibodies by gene transfection.
    Songsivilai S; Clissold PM; Lachmann PJ
    Biochem Biophys Res Commun; 1989 Oct; 164(1):271-6. PubMed ID: 2803299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule.
    Hoogenboom HR; Raus JC; Volckaert G
    Biochim Biophys Acta; 1991 Jun; 1096(4):345-54. PubMed ID: 2065106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
    J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of heavy-chain class-switch variants of human monoclonal antibody by recombinant DNA technology.
    Komori S; Yamasaki N; Shigeta M; Isojima S; Watanabe T
    Clin Exp Immunol; 1988 Mar; 71(3):508-16. PubMed ID: 3133144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
    Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.
    Walls MA; Hsiao KC; Harris LJ
    Nucleic Acids Res; 1993 Jun; 21(12):2921-9. PubMed ID: 8332501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody engineering at the millennium.
    Gavilondo JV; Larrick JW
    Biotechniques; 2000 Jul; 29(1):128-32, 134-6, 138 passim. PubMed ID: 10907088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibodies: strategies for production and application.
    Morrison SL
    Annu Rev Immunol; 1992; 10():239-65. PubMed ID: 1590987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level synthesis of immunoglobulins in Chinese hamster ovary cells.
    Wood CR; Dorner AJ; Morris GE; Alderman EM; Wilson D; O'Hara RM; Kaufman RJ
    J Immunol; 1990 Nov; 145(9):3011-6. PubMed ID: 2120343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.
    Sun LK; Curtis P; Rakowicz-Szulczynska E; Ghrayeb J; Chang N; Morrison SL; Koprowski H
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):214-8. PubMed ID: 3025856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered antibody molecules: new tools for cancer therapy.
    Morrison SL; Wims LA; Oi VT
    Cancer Invest; 1988; 6(2):185-92. PubMed ID: 3288296
    [No Abstract]   [Full Text] [Related]  

  • 16. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
    Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
    Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetically engineered single-gene-encoded anti-TAG72 chimeric antibody secreted from myeloma cells.
    Qi Y; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):161-6. PubMed ID: 8688499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered antibodies: progress and prospects.
    Wright A; Shin SU; Morrison SL
    Crit Rev Immunol; 1992; 12(3-4):125-68. PubMed ID: 1476621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, expression, and modification of antibody V regions.
    Morrison SL
    Curr Protoc Immunol; 2002 May; Chapter 2():Unit 2.12. PubMed ID: 18432877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organization of four mouse lambda light chain immunoglobulin genes.
    Blomberg B; Traunecker A; Eisen H; Tonegawa S
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3765-9. PubMed ID: 6791160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.